Articles & courses

ArticlesShow all 38
Principles and Preparations for Echocardiographic Examinations

…have been propelled by breakthroughs in engineering, software development, and progress in our understanding of the pathophysiology of cardiac disease. Ultrasound systems have become cheaper…

Myocardial Ischemia & infarction: Cellular changes, ECG and symptoms

ECG Myocardial ischemia and infarction Myocardial ischemia: cellular changes, ECG signs and development of infarction Like all other cells in the human body, cardiac myocytes…

Acquired QT Prolongation and Drug-Induced Arrhythmia

…or the development of an entirely new arrhythmia. Electrophysiologic mechanisms of proarrhythmia include prolongation of repolarisation, increased transmural dispersion, EAD mediated TdP, and alterations in…

Drug-Eluting Coronary Stents: Evolution, Evidence and Stent Choice

…delivery system, and an antiproliferative agent. Their development has improved procedural safety, reduced repeat revascularization, and broadened the range of lesions amenable to PCI. Stent…

Sinus node dysfunction (SND) and sick sinus syndrome (SSS)

…the impulse from reaching the atria. Disturbed automaticity and blocked impulses lead to arrhythmias that characterize sinus node dysfunction. The conditions encircled by the term…

Hypertriglyceridaemia: Management and Cardiovascular Risk

…disease. The relationship between triglyceride concentrations and aortic disease is less clearly defined, although triglycerides may contribute to the development and progression of aortic pathology…

Atrial Flutter: Mechanisms, ECG Recognition and Management

…similar clinical settings and frequently coexist in the same patient population. AF can act as a trigger for atrial flutter, and the development of AF…

Alcohol and Cardiovascular Disease

…hypertension and atherosclerotic coronary disease In patients with heavy alcohol use, left ventricular dilation may precede the development of increased left ventricular hypertrophy and mass…

Colchicine and Anti-inflammatory Therapy in Coronary Disease

…infarction and non fatal stroke. The clinical development of canakinumab for this indication did not continue because of safety concerns, particularly fatal infections, and because…

Obesity and Cardiovascular Disease: Assessment and Treatment

…A prothrombotic state Albuminuria and declining estimated glomerular filtration rate Development of type 2 diabetes mellitus Atherosclerotic cardiovascular events HF and atrial fibrillation Obesity therefore…

Media

No matches.

Tests

Tools